BuPROPion Hydrochloride Extended-Release Tablets, USP (XL) 300 mg, Rx Only, 500-count bottles, Manufactured by Cadila Healthcare Ltd. Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA inc. Pennington, NJ 08534, NDC 68382-354-05
Published November 30, 2016 · Recall initiated: August 3, 2016
Summary
FDA records drug Class III recall D-0149-2017, published November 30, 2016 and initiated August 3, 2016. Recalling firm: Zydus Pharmaceuticals USA Inc; Status: Terminated; Reported quantity: 2,472 units; Lot: Lot #: MR3365, Exp. Feb 17. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications: Product did not meet dissolution specification at an intermediate time point.
What to do
Voluntary: Firm initiated · Letter
Get an email if BUPROPION has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- BUPROPION
- Manufacturer
- Zydus Pharmaceuticals USA Inc
- Distributor
- Nationwide
- Lot
- Lot #: MR3365, Exp. Feb 17
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDABuPROPion Hydrochloride Extended-Release Tablets (XL), 300 mg, Rx Only, a) 30 count bottles (NDC 68382-354-06)December 28, 2016
- FDAKENALOG (Triamcinolone Acetonide) Spray with Spray Tube Topical Aerosol, USP, (0.147 mg/g), 15 g bottle,November 30, 2016
- FDADiltiazem HCl Extended-release Capsules, USP 120 mg, 100-count bottle (NDC 0378-5220-01), 500-count bottleNovember 30, 2016
- FDAAmoxicillin for Oral suspension, USP 400 mg/5 mL, 100 mL (when reconstituted), Rx only, Manufactured by: HikmaNovember 30, 2016
- FDADesoximetasone Ointment USP, 0.25%, a) 15 g tubes (NDC 61748-206-15 and b) 60 g tubes (NDC 61748-206-60,November 30, 2016
- FDALactulose Solution, USP, 10 g/15 mL, 15 mL unit dose cups (NDC 66689-039-01), packaged in 15 mL x 50 unit doseNovember 30, 2016
Questions about this recall
Was BuPROPion Hydrochloride Extended-Release Tablets, USP (XL) 300 mg, Rx Only, 500-count bottles, Manufactured by Cadila Healthcare Ltd. Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA inc. Pennington, NJ 08534, NDC 68382-354-05 recalled?
Yes. FDA published recall D-0149-2017 on November 30, 2016. Reported hazard: Failed Dissolution Specifications: Product did not meet dissolution specification at an intermediate time point.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: BUPROPION.